Galapagos NV
GLPG
$28.63
Share price
-0.49%
Change (1 day)
-25.38%
Change (1 year)
Categories
Galapagos NV (GLPG) - Net assets
Net assets on the balance sheet as of September 2023 : $2.76 B
According to Galapagos NV's latest financial reports the company has $2.76 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Galapagos NV - Net assets on balance sheet (from 2008 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $2.70 B | -9.63% |
| 2021-12-31 | $2.99 B | -8.86% |
| 2020-12-31 | $3.28 B | 1.96% |
| 2019-12-31 | $3.22 B | 131.91% |
| 2018-12-31 | $1.38 B | 14.34% |
| 2017-12-31 | $1.21 B | 52.11% |
| 2016-12-31 | $0.79 B | 100.13% |
| 2015-12-31 | $0.39 B | 59.19% |
| 2014-12-31 | $0.25 B | 8.62% |
| 2013-12-31 | $0.23 B | 47.32% |
| 2012-12-31 | $0.15 B | 2.13% |
| 2011-12-31 | $0.15 B | -22.33% |
| 2010-12-31 | $0.19 B | 26.63% |
| 2009-12-31 | $0.15 B | 32.32% |
| 2008-12-31 | $0.11 B | -18.14% |
| 2007-12-31 | $0.14 B | -0.55% |
| 2006-12-31 | $0.14 B | 100.44% |
| 2005-12-31 | $72.24 M | 413.72% |
| 2004-12-31 | $14.06 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 2,383.05% | 🇺🇸 USA |
 Abbott Laboratories ABT | $38.82 B | 1,301.83% | 🇺🇸 USA |
 AbbVie ABBV | $10.39 B | 275.38% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 2,867.91% | 🇫🇷 France |
 Merck MRK | $37.63 B | 1,258.79% | 🇺🇸 USA |
 AstraZeneca AZN | $39.16 B | 1,314.07% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $16.28 B | 488.07% | 🇬🇧 UK |
 Fortress Biotech
FBIO | -$13.25 M | -100.48% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $8.12 B | 193.38% | 🇮🇱 Israel |